Current Pattern of Use and Impact of Pringle Maneuver in Liver Resections in the United States

J Surg Res. 2019 Jul:239:253-260. doi: 10.1016/j.jss.2019.01.043. Epub 2019 Mar 8.

Abstract

Background: Pringle maneuver (PM) is used for inflow vascular control during hepatectomy, but its use remains controversial. We aimed to report its pattern of use and association with postoperative outcomes.

Methods: We identified hepatectomy patients using the liver-targeted National Surgical Quality Improvement Program database (2014-2016). Associations between PM and posthepatectomy liver failure (PHLF), receipt of blood transfusion, and total hospital length of stay (LOS) were evaluated.

Results: We identified 7870 patients (74.9%) with no Pringle maneuver and 2632 (25.1%) with PM. PM patients were older (median age 61 versus 60 y, P = 0.002) and had higher ASA scores (76.1% versus 71.4% were ASA 3-4, P < 0.001). PM had more malignancy (83.0% versus 73.0%, P < 0.001), neoadjuvant therapy (37.7% versus 28.8%, P < 0.001), total lobectomy (30.6% versus 23.2%, P < 0.001), open resection (90.8% versus 74.9%, P < 0.001), and longer operations (246 min versus 212 min, P < 0.001). PM was associated with longer LOS (0.36 d, 95% confidence interval [CI] 0.11-0.60) and increased risk of PHLF (odds ratio [OR] 1.36, 95% CI 1.11-1.66), although not clinically significant grade B/C PHLF (OR 0.82, 95% CI 0.57-1.19), but was not associated with receipt of perioperative blood transfusions (OR 1.00, 95% CI 0.69-1.64).

Conclusions: PM is associated with similar clinically significant PHLF and transfusion requirements but longer LOS compared with no Pringle maneuver.

Keywords: Hepatectomy; Inflow vascular occlusion; Liver resection; Pringle maneuver; Surgical outcomes.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Blood Loss, Surgical / prevention & control
  • Blood Transfusion / statistics & numerical data
  • Female
  • Hepatectomy / adverse effects*
  • Hepatectomy / methods
  • Hepatectomy / statistics & numerical data
  • Humans
  • Length of Stay / statistics & numerical data
  • Liver Failure / epidemiology*
  • Liver Failure / etiology
  • Liver Neoplasms / therapy*
  • Male
  • Middle Aged
  • Neoadjuvant Therapy / adverse effects
  • Neoadjuvant Therapy / statistics & numerical data
  • Operative Time
  • Postoperative Complications / epidemiology*
  • Postoperative Complications / etiology
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Retrospective Studies
  • United States / epidemiology